These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 19181271)
41. Stephens RW; Tredwell GD; Knox KJ; Philip LA; King DW; Debono KM; Bell JL; Senden TJ; Tanudji MR; Winter JG; Bickley SA; Tapner MJ; Jones SK Int J Nanomedicine; 2019; 14():889-900. PubMed ID: 30774340 [TBL] [Abstract][Full Text] [Related]
42. 99mTc-tricarbonyl labeled agents for cell labeling: development, biodistribution in normal mice and preliminary in vitro evaluation. Fonge H; Jin L; Cleynhens J; Bormans G; Verbruggen A Bioorg Med Chem; 2010 Jan; 18(1):396-402. PubMed ID: 19926292 [TBL] [Abstract][Full Text] [Related]
43. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts. Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099 [TBL] [Abstract][Full Text] [Related]
45. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium. Hoffend J; Linke G; Mohammed A; Tiefenbacher CP; Eisenhut M; Haberkorn U Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):494-501. PubMed ID: 12574972 [TBL] [Abstract][Full Text] [Related]
46. Phase I clinical trial of 99mTc-etarfolatide, an imaging agent for folate receptor in healthy Japanese adults. Yamada Y; Nakatani H; Yanaihara H; Omote M Ann Nucl Med; 2015 Nov; 29(9):792-8. PubMed ID: 26238440 [TBL] [Abstract][Full Text] [Related]
47. Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by (99m)Tc-HMPAO labeling. Park BN; Shim W; Lee G; Bang OY; An YS; Yoon JK; Ahn YH Nucl Med Biol; 2011 Nov; 38(8):1175-82. PubMed ID: 21831649 [TBL] [Abstract][Full Text] [Related]
48. Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues. He H; Lipowska M; Christoforou AM; Marzilli LG; Taylor AT Nucl Med Biol; 2007 Aug; 34(6):709-16. PubMed ID: 17707812 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of 99mTcN-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis. Fang W; Liu Y; Zhu L; Kim YS; Liu S; He ZX Nucl Med Commun; 2008 Sep; 29(9):775-81. PubMed ID: 18677204 [TBL] [Abstract][Full Text] [Related]
50. Novel Approach for Liu M; Zhao ZQ; Fang W; Liu S Bioconjug Chem; 2017 Dec; 28(12):2998-3006. PubMed ID: 29148726 [TBL] [Abstract][Full Text] [Related]
51. Novel Liu M; Zheng Y; Avcibasi U; Liu S Nucl Med Biol; 2016 Nov; 43(11):732-741. PubMed ID: 27632344 [TBL] [Abstract][Full Text] [Related]
52. Preclinical Assessment of Alkandari AM; Shafaa MW; Alsayed YM J Nucl Med Technol; 2020 Sep; 48(3):269-273. PubMed ID: 32518123 [TBL] [Abstract][Full Text] [Related]
53. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors. Taki J; Sumiya H; Higuchi T; Tsuchiya H; Takazawa K; Tomita K; Tonami N J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547 [TBL] [Abstract][Full Text] [Related]
54. Alteration of the organ uptake of the (99m)Tc-radiopharmaceuticals, (99m)Tc-DPD, (99m)Tc-DMSA, (99m)Tc-tin colloid and (99m)Tc-MAA, induced by the applied cytotoxic drugs methotrexate sodium and cyclophosphamide. Janković DLj; Djokić DDj Nucl Med Commun; 2005 May; 26(5):415-9. PubMed ID: 15838423 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors. Chen Y; Huang ZW; He L; Zheng SL; Li JL; Qin DL Appl Radiat Isot; 2006 Mar; 64(3):342-7. PubMed ID: 16290170 [TBL] [Abstract][Full Text] [Related]
56. PET lung ventilation/perfusion imaging using (68)Ga aerosol (Galligas) and (68)Ga-labeled macroaggregated albumin. Ament SJ; Maus S; Reber H; Buchholz HG; Bausbacher N; Brochhausen C; Graf F; Miederer M; Schreckenberger M Recent Results Cancer Res; 2013; 194():395-423. PubMed ID: 22918772 [TBL] [Abstract][Full Text] [Related]
57. Preparation and biodistribution of a (99m)Tc tricarbonyl complex with deoxyglucose dithiocarbamate as a tumor imaging agent for SPECT. Lin X; Chao X; Zhang J; Jin Z; Zhang Y Bioorg Med Chem Lett; 2014 Aug; 24(16):3964-7. PubMed ID: 24985567 [TBL] [Abstract][Full Text] [Related]
58. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653 [TBL] [Abstract][Full Text] [Related]
59. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography. Hayashida K; Fukuchi K; Inubushi M; Fukushima K; Imakita S; Kimura K J Nucl Med; 2001 Jun; 42(6):859-63. PubMed ID: 11390548 [TBL] [Abstract][Full Text] [Related]
60. Macrocyclic triamine derived glucose analogues for Liu T; Gan Q; Zhang J Chem Biol Drug Des; 2017 Feb; 89(2):277-284. PubMed ID: 28205404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]